A proportion of non-enhancing intrinsic presumed low-grade-gliomas(LGG), rapidly progresses. Hypothesis: ADC can predict glioma molecular subtypes of the revised 2016 World_Health_Organization brain tumours classification. Methods..44 non-Gadolinium-enhancing LGG divided in three molecular subgroups. 2D and 3D T2-derived tumour and normal-appearing-white-matter (NAWM) masks co-registered to ADC_maps(b=1000s/mm2). Linear-regression, ROC-analysis and logistic-regression compared ADC_values with tumour type. Results..ADCmean and ADCratio(tumour/NAWM) were lowest (p<0.001) in the most malignant tumour type (IDHwt). An ADCmean(ADCratio) threshold of 1201*10-6mm2/s(1.65) identified IDHwt with sensitivity=83%(80%) and specificity=86%(92%) (AUC=0.9-0.94). Between-observers (2D-versus-3D) intraclass-correlation-coefficient=0.98(0.92). Conclusions..ADC measurements can support the distinction of non-enhancing glioma subtypes. 3D and 2D measurements were both accurate.